Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable' - E

Logo BenzingaBenzinga
2023-06-08 15:27:15  • 3 mins

SenatorBernie Sandersurged the U.S. Department of Health and Human Services (HHS) to immediately address the exorbitant cost ofEisai Co LtdESALY/Biogen IncBIIB Alzheimer's treatment Leqembi (lecanemab).

Wednesday, the FDA released briefing documents ahead of the meeting that appears to support afull FDA approval for Leqembi.

In a letter to HHS Secretary Xavier Becerra, Sanders, who chairs the Senate Health Committee, expressed his deep concern over the annual price for Leqembi at $26,500, which he described as "unconscionable."

Sanders emphasized that the current price of Leqembi would place a significant financial burden on Medicare and lead to increased premiums for seniors.

Sanders called on HHS to utilize its authority to break the patent monopoly on Leqembi if Eisai and Biogen refuse to lower the treatment's price. He also suggested that the Centers for Medicare and Medicaid Services (CMS) could restrict the amount it pays for Leqembi, ensuring that the reimbursement aligns with the drug's benefit.

Continue read on

TOKYO (AP) Japan's health ministry has approved Leqembi, a drug for Alzheimers disease that was jointly developed by Japanese and U.S. pharmaceutical...
Logo U.S. News & World ReportU.S. News & World Report
2023-09-26 06:18:59  • 1 min
Eisai Co Ltd ESALY ESALF and Biogen Inc BIIB announced that humanized anti-soluble aggregated amyloid-beta (A) monoclonal antibody Leqembi Intravenous...
Logo BenzingaBenzinga
2023-09-25 14:41:44  • 2 mins
Italy-based Alfasigma has agreed to acquire Intercept Pharmaceuticals Inc ICPT for $19.00 per share in cash. The purchase price represents a premium of 82%...
Logo BenzingaBenzinga
2023-09-26 13:30:10  • 1 min
(RTTNews) - Biogen Inc. (BIIB) has completed the acquisition of Reata Pharmaceuticals, Inc. (RETA). As a result, Biogen has now acquired SKYCLARYS, and other...
Logo NasdaqNasdaq
2023-09-26 14:03:36  • 1 min
Despite significant initiatives by generic drug companies to broaden access to vital medicines, many vulnerable patients remain underserved, according to...
Logo BenzingaBenzinga
2023-09-26 14:52:49  • 1 min
Fintel reports that on September 26, 2023, JMP Securities maintained coverage of Benitec Biopharma ( NASDAQ:BNTC ) with a Market Outperform recommendation....
Logo NasdaqNasdaq
2023-09-26 22:31:25  • 1 min
Fintel reports that on September 26, 2023, UBS maintained coverage of Cymabay Therapeutics ( NASDAQ:CBAY ) with a Buy recommendation. Analyst Price Forecast...
Logo NasdaqNasdaq
2023-09-26 14:58:08  • 1 min
(RTTNews) - Ionis Pharmaceuticals Inc. (IONS) announced positive results for the Phase 3 Balance study of olezarsen in people with familial chylomicronemia...
Logo NasdaqNasdaq
2023-09-26 11:54:17  • 1 min
Health care stocks were leaning lower premarket Tuesday, with the iShares Biotechnology ETF ( IBB ) was marginally declining and the Health Care Select...
Logo NasdaqNasdaq
2023-09-26 13:18:01  • 1 min
(RTTNews) - ZimVie Inc. (ZIMV) announced that on September 7, 2023, the FDA approved its Mobi-C Cervical Disc Hybrid Investigational Device Exemption...
Logo NasdaqNasdaq
2023-09-26 12:45:38  • 1 min
(RTTNews) - Vigil Neuroscience, Inc. (VIGL) Tuesday said it received positive opinion from EMA's Committee for Orphan Medicinal Products (COMP) for the...
Logo NasdaqNasdaq
2023-09-26 11:50:13  • 1 min
The FDA issued a Complete Response Letter regarding the Biologics License Application supplement for Udenyca Onbody, Coherus BioSciences Inc's CHRS on-body...
Logo BenzingaBenzinga
2023-09-25 19:35:07  • 1 min
Fintel reports that on September 26, 2023, Oppenheimer upgraded their outlook for Edwards Lifesciences ( NYSE:EW ) from Perform to Outperform. Analyst Price...
Logo NasdaqNasdaq
2023-09-26 11:40:42  • 1 min
Health care stocks were lower Tuesday afternoon with the NYSE Health Care Index falling 0.6% and the Health Care Select Sector SPDR Fund (XLV) down 0.8%. The...
Logo NasdaqNasdaq
2023-09-26 17:51:06  • 1 min
Health care stocks were declining late Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each down 0.9%....
Logo NasdaqNasdaq
2023-09-26 19:48:39  • 1 min
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively...
Logo NasdaqNasdaq
2023-09-26 10:20:05  • 1 min
Health care stocks were higher Monday afternoon with the NYSE Health Care Index rising 0.3% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%. The...
Logo NasdaqNasdaq
2023-09-25 17:46:37  • 1 min
(RTTNews) - Phathom Pharmaceuticals, Inc. (PHAT), a biopharmaceutical company focused on gastrointestinal or GI diseases, announced Tuesday the submission of...
Logo NasdaqNasdaq
2023-09-26 13:05:01  • 1 min
(RTTNews) - Sanofi (SNY) announced the FDA has accepted for Priority Review the supplemental Biologics License Application for Dupixent to treat children...
Logo NasdaqNasdaq
2023-09-26 05:58:34  • 1 min
(RTTNews) - Biotechnology companies Dyadic International, Inc. (DYAI) and France's bYoRNA SAS announced Tuesday that they entered into a development and...
Logo NasdaqNasdaq
2023-09-26 14:06:30  • 1 min